Falsified Quinine Sulphate 300MG in Circulation, NAFDAC Warns

NLIPW News

September 18, 2016 – The National Agency for Food and Drug Administration and Control (NAFDAC) recently issued a warning regarding the circulation of falsified Quinine Sulphate 300mg tablet versions in Cameroon and the Democratic Republic of Congo.  The products have been found to contain zero active pharmaceutical ingredients.

Quinine Sulphate is an anti-malaria drug used for the treatment of Plasmodium falciparum Malaria. These falsified products were first discovered by a local NGO on failing field screening. They were submitted to a WHO pre-qualified Quality Assurance Laboratory and subsequent analysis from the laboratory showed neither of the products contained any of the stated active ingredients.

The details of the falsified products are:

Product 1 Product 2
Product Name: Quinine Sulphate 300mg

Manufacturer: Novadina Pharmaceutical Ltd, London, United Kingdom

Number of tablets per container: 1000

Batch Number: 10H05

Date of Manufacture:  09/2014

Expiry date: 09/2018

Product Name: Quinine Sulphate 300mg

Manufacturer: CAD Pharm, India

Number of tablets per container: 100

Batch Number: F4387

Date of Manufacture:  12/14

Expiry date: 11/18

NAFDAC implores importers, distributors, retailers and the general public to ensure vigilance and avoid the purchase of the confirmed falsified products.

All distributors, retailers and members of the public with these falsified products should submit products to the nearest NAFDAC office for destruction.

Print Friendly, PDF & Email
FILE A TRADEMARK
About Bob Aroture 551 Articles
Bob is a Senior Editor and Content Development Manager at Nigerian Law Intellectual Property Watch. He holds a BS degree, with a major in biochemistry. He works directly with the Newsroom Team. His focus areas are technology and innovation, and pharmaceutical technology. Email: editorial@nlipw.com